Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Denovo Biopharma
AddedFeb 13, 2024
UpdatedJun 18, 2026
Denovo Biopharma

Denovo Biopharma

Series D

Denovo Biopharma, LLC: A private US biotech firm specializing in personalized drug development solutions.

HQ
San Diego, CA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Denovo Biopharma, LLC, founded as a private biotechnology company, focuses on providing innovative biomarker solutions to personalize drug development. The company's mission is to enhance the effectiveness and safety of pharmaceuticals by identifying genetic markers that predict patient response to specific drugs. Denovo Biopharma's services include genomic analysis and biomarker discovery, primarily targeting the U.S. market. Their approach aims to streamline clinical trials and reduce the risk and cost associated with drug development.

Notable figures associated with Denovo Biopharma include experienced professionals in biotechnology and genomic research. The company has attracted investments from prominent venture capital firms specializing in life sciences. Key achievements include the successful identification of biomarkers that have improved the efficacy of several drug candidates in clinical trials. Denovo Biopharma's impact lies in its potential to revolutionize personalized medicine, making treatments more effective and reducing adverse effects for patients.

Denovo Biopharma - Similar Companies

Sinogen Biopharma logo

Sinogen Biopharma

Denali Therapeutics logo

Denali Therapeutics

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

Know Bio logo

Know Bio

knowbiollc.com

Genomind logo

Genomind

genomind.com

Eve Biomedical logo

Eve Biomedical

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

Novita Therapeutics logo

Novita Therapeutics

Geneicd logo

Geneicd

Adipogenix logo

Adipogenix

Novoron Bioscience logo

Novoron Bioscience

novoron.com

VivoSim Labs logo

VivoSim Labs

organovo.com

Genomenon logo

Genomenon

genomenon.com

BridGene Biosciences logo

BridGene Biosciences

Curie.Bio logo

Curie.Bio

curie.bio

Denovo Biopharma - Quick Facts

Who are Denovo Biopharma's competitors?

Companies similar to Denovo Biopharma include Sinogen Biopharma, Denali Therapeutics, BridgeBio Pharma and Know Bio.

When was Denovo Biopharma founded?

Denovo Biopharma was founded in 2011.

Where is Denovo Biopharma's headquarters located?

Denovo Biopharma's headquarters is located in San Diego, CA, US.

When was Denovo Biopharma's last funding round?

Denovo Biopharma's most recent funding round was for $300M (USD) in December 2020.

How much has Denovo Biopharma raised to-date?

As of Dec 10, 2020, Denovo Biopharma has raised a total of $1.2B (USD).

How many employees does Denovo Biopharma have?

Denovo Biopharma has 36 employees as of Feb 4, 2024.

Denovo Biopharma - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotechnology
  • Drug Development
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified